InvestorsHub Logo
Followers 0
Posts 232
Boards Moderated 0
Alias Born 06/13/2010

Re: None

Saturday, 05/21/2011 10:50:05 AM

Saturday, May 21, 2011 10:50:05 AM

Post# of 80490
2011 Predictions (or at worse, my wish list)



1- Merck files a Ridaforolimus NDA by no later than July 30th 2011

2- FDA approves Ridaforloimus by 4th quarter 2011 or first quarter 2012

3- Ariad partners Ponatinib in Asia before years end

4- Ariad announces a new compound before years end

5- Ponatinib clinical trial is fully enrolled by August 15th 2011

6- Before years end, Ariad reveals preliminary data on Pona clinical trial

7- Ariad initiates a Phase 1 clinical trial for 113 by July 15th 2011

8- Ariad shares trade at $20.00 a share (some time before Christmas)

9- Ten (10) of the Ariad message board member, meet in Manhattan for a lobster dinner and party, prior to New Year's Eve


As usual this is JMHO,
Barry

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.